NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.23
-4.77 (-1.88%)
AAPL  270.06
+1.01 (0.38%)
AMD  251.83
-7.82 (-3.01%)
BAC  53.51
-0.05 (-0.10%)
GOOG  277.58
-6.54 (-2.30%)
META  628.72
-8.99 (-1.41%)
MSFT  513.49
-3.54 (-0.68%)
NVDA  199.44
-7.44 (-3.60%)
ORCL  246.26
-11.59 (-4.50%)
TSLA  448.17
-20.20 (-4.31%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.